Have a personal or library account? Click to login
Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients Cover

Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients

Open Access
|Jun 2019

References

  1. 1. FOX KM., WANG L., GANDRA SR., QUEK RG., LI L., BASER O. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:13.10.1186/s12872-016-0190-x
  2. 2. CANIS M., OLZOWY B., WELZ C., SUCKFULL M., STELTER K. Simvastatin and Ginkgo biloba in the treatment of subacute tinnitus: a retrospective study of 94 patients. Am J Otolaryngol. 2011;32(1):19-23.10.1016/j.amjoto.2009.09.004
  3. 3. MARON DJ., FAZIO S., LINTON MF. Current perspectives on Statins. Circulation. 2000; 18;101(2):207-13.10.1161/01.CIR.101.2.207
  4. 4. FERON O., DESSY C., DESAGER JP., BALLIGAND JL. Hydroxy-methylglutaryl- coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 2001;103(1):113-8.10.1161/01.CIR.103.1.113
  5. 5. KUK FK., TYLER RS., RUSSEL D., JORDAN H. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear. 1990;11(6):434-45.10.1097/00003446-199012000-00005
  6. 6. MEIKLE MB., GRIEST SE., STEWART BJ., PRESS LS. Measuring the negative impact of tinnitus: A brief severity index. Abstr Assoc Res Otolaryngol. 1995;167.
  7. 7. NEWMAN CW., JACOBSON GP., SPITZER JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122(2):143-8.10.1001/archotol.1996.01890140029007
  8. 8. JERGER J., JERGER S. Measuring of hearing in adults, In Paparella MM, Shumrick DA, eds, Otolaryngology, 2nd ed, Philadephia 1980;1226.
  9. 9. NGUYEN TV., BROWNELL WE. Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Otolaryngol Head Neck Surg. 1998;119(1):14-20.10.1016/S0194-5998(98)70167-6
  10. 10. CANIS M., SCHMID J., OLZOWY B., JAHN K., STRUPP M., BERGHAUS A., et al. The influence of cholesterol on the motility of cochlear outer hair cells and the motor protein prestin. Acta Otolaryngol. 2009;129(9):929-34.10.1080/00016480802495438
  11. 11. CANIS M., HEIGL F., SUCKFUEL M. Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss. Clin Res Cardiol Suppl. 2012;7:36-40.10.1007/s11789-012-0044-8
  12. 12. SUCKFULL M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet. 2002;360(9348):1811-7.10.1016/S0140-6736(02)11768-5
  13. 13. PARK JS., KIM SW., PARK K., CHOUNG YH., JOU I., PARK SM. Pravastatin attenuates noise-induced cochlear injury in mice. Neuroscience. 2012;208:123-32.10.1016/j.neuroscience.2012.02.010
  14. 14. BRECHTELSBAUER PB., NUTTALL AL., MILLER JM. Basal Nitric Oxide production in regulation of cochlear blood flow. Hear Res. 1994;77(1-2):38-42.10.1016/0378-5955(94)90251-8
  15. 15. GLORIOSO N., TROFFA C., FILIGHEDDU F., DETTORI F., SORO A., PARPAGLIA PP., et al. Effect of the HMGCoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension. 1999;34:1281-6.10.1161/01.HYP.34.6.1281
  16. 16. VAUGHAN CJ., GOTTO AM., BASSON CT. The Evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35(1):1-10.10.1016/S0735-1097(99)00525-2
  17. 17. BORGHI C., MODUGNO C., PIRADDA A. Possible Role of HMG-CO A Reductase inhibitors for the treatment of sudden sensorineural hearing loss (SSHL). Med Hypotheses. 2002;58(5):399-402.10.1054/mehy.2001.153512056877
  18. 18. CAI Q., DU X., ZHOU B., CAI C., KERMANY MH., ZHANG C., et al. Effects of Simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene–deficient mice. ORL J Otorhinolaryngol Relat Spec. 2009;71(5):244-50.10.1159/00023601419738398
  19. 19. SYKA J., OUDA L., NACHTIGAL P., SOLICHOVA D., SEMECKÝ V. Atorvastatin slows down deterioration of inner ear function with age in mice. Neurosci Lett. 2007;411(2):112-6.10.1016/j.neulet.2006.10.03217084973
  20. 20. OLZOWY B., CANIS M., HEMPEL JM., MAZUREK B., SUCKFULL M. Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly. Otol Neurotol. 2007;28(4):455-8.10.1097/01.mao.0000271673.33683.7b17529847
  21. 21. CHUNG SD., CHEN CH., HUNG SH., LIN HC., WANGLH. A population-based study on the association between statin use and sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2015;152(2):319-25.10.1177/019459981455938225450412
  22. 22. LİU M., ALAFRİS A., LONGO AJ., COHEN H. Irreversible atorvastatin-associated hearing loss. Pharmacotherapy. 2012;32(2):e27-34.10.1002/PHAR.104022392429
  23. 23. SİERRA S., RAMOS MC., MOLİNA P., ESTEO C., VÁZQUEZ JA., BURGOS JS. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis. 2011;23(2):307-18.10.3233/JAD-2010-10117921098985
  24. 24. MELO JJ., MENESES CL., MARCHIORI LL. Prevalence of tinnitus in elderly individuals with and without history of occupational noise exposure. Int Arch Otorhinolaryngol. 2012;16(2):222-5.10.7162/S1809-97772012000200011439959125991939
  25. 25. MOLLER AR. Pathophysiology of Tinnitus. Ann Otol Rhinol Laryngol. 1984;93:39-44.10.1177/000348948409300110
  26. 26. PEIFER KJ., ROSEN GP., RUBIN AM. Tinnitus; Etiology and management, Clin Geriatr Med. 1999;15(1):193-204.10.1016/S0749-0690(18)30082-X
  27. 27. GUITTON M., CASTON J., RUEL J., JOHNSON R. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci. 2003;23(9):3944-52.10.1523/JNEUROSCI.23-09-03944.2003
  28. 28. HAMEDD MK., SHEIKH ZA., AHMED A., NAJAM A. Atorvastatin in the management of tinnitus with hyperlipidemias. J Coll Physicians Surg Pak. 2014;24(12):927-30.
DOI: https://doi.org/10.2478/rjim-2018-0035 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 133 - 140
Submitted on: Sep 18, 2018
|
Published on: Jun 20, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Hilal Yücel, Abitter Yücel, Hamdi Arbağ, Erkan Cure, Mehmet Akif Eryilmaz, Ahmet Bedri Özer, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.